Nano Labs Appoints Dr. David Perry to the Board of Advisors

Nano Labs Corp. Logo

DETROIT, May 2, 2013 (GLOBE NEWSWIRE) -- Nano Labs Corp. (OTCQB:CTLE), a nanotechnology research and development company focused on creating a portfolio of advanced products in the consumer, energy, materials and healthcare industries, is pleased to announce today that Dr. David Perry has joined Nano Labs' Board of Advisors.

Dr. Perry is recognized worldwide as an expert in Technology Innovation and has held a number of senior management positions throughout his career spanning 5 continents and 35 years, both in Industry and Academia.

Dr. Perry studied at the Pasteur Institute in Paris, has authored over 40 papers and patents and has worked with and/or founded a very broad range of companies, from start-ups to multinationals in, Innovation Management, High Technology, Biotechnology, Pharmaceuticals, Cosmetics, Agro-food and Clean Technology.

Dr. Perry is currently Director of Development and International Affairs at Hautes Etudes d'Ingénieur (HEI), Ingénieurs pour le Monde (Engineers for the World), a member of the CGE, the French Ivy League of Engineering and Business Schools, where he has successfully deployed his technical, managerial and political skills in expanding the Global Industrial and Academic Programs and Partnerships at HEI.

"I am indeed both honored and proud to be a part of Nano Labs, the people are engaged, the markets are ready, the technologies are empowering, the impact on people's welfare is evident and the good they can do for the World, unmistakable," states Dr. Perry.

Dr. Perry has held positions as an Adjunct Professorship at the following institutions: School of Applied Biology, Paris, France; University of Toulouse, France; Barcelona University, Spain; Düsseldorf University, Germany; Armand Frappier Institute, Montreal, Canada; Laval University, Ste. Foy, Quebec, Canada; Concordia University, Montreal, Canada; University of Waterloo, Waterloo, Ontario, Canada and the University of Wageningen, Holland; and as a Visiting Professor at the University of Virginia, Mountain Lake Biological Station.

About Nano Labs

Nano Labs Corp. (OTCQB:CTLE) is a nanotechnology company which is able to access resources that encompass nearly 30 years of research and development in nanotechnology as well as hundreds of peer-reviewed and published research papers and other scholarly material. The Company's research and development team of scientists, designers, and engineers is focused on creating a portfolio of advanced products that could provide benefits to a variety of industries including: (i) consumer products, (ii) energy, (iii) materials, and (iv) healthcare. Through the use and integration of proprietary nano compounds, our goal is to evolve common products into new, revolutionary products in order to make the world a better place. Nano Labs shares are traded on the OTC Bulletin Board in the United States under the ticker CTLE. For more information, please visit

The Nano Labs Corp. logo is available at

Forward looking statements

This press release contains forward-looking information within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 and is subject to the safe harbor created by those laws. These forward-looking statements are based upon a number of assumptions and estimates that are subject to significant uncertainties that involve known and unknown risks, many of which are beyond our control and are not guarantees of future performance. Actual outcomes and results could materially differ from what is expressed, implied, or forecasted in any such forward-looking statements and any such difference may be caused by risk factors listed from time to time in the Company's news releases and/or its filings with the OTC Bulletin Board or as a result of other factors.

CONTACT: Nano Labs Corp. Bernardo Camacho Chavarria President 1 (888) 806-2315

Source:Nano Labs Corp.